TABLE 1.
Clinical and laboratory characteristics
Lean | Obese | Type 2diabetes | |
---|---|---|---|
n | 8 | 8 | 12 |
Sex (male/female) | 5/3 | 3/5 | 4/8 |
Age (years) | 45 ± 3 | 44 ± 4 | 53 ± 3 |
BMI (kg/m2) | 25.5 ± 1.0 | 30.5 ± 1.0* | 31.5 ± 1.2* |
Glucose (mmol/l) | 5.3 ± 0.2 | 5.6 ± 0.1 | 7.7 ± 0.7*† |
A1C (%) | 5.0 ± 0.1 | 4.9 ± 0.2 | 6.3 ± 0.3*† |
Insulin (pmol/l) | 44 ± 3 | 126 ± 19* | 85 ± 13*† |
FFA (μmol/l) | 430 ± 40 | 510 ± 50 | 700 ± 40*† |
Insulin sensitivity index | 6.5 ± 0.9 | 3.1 ± 0.5* | 3.4 ± 0.8* |
Adiponectin (μg/ml) | 22.4 ± 3.0 | 15.4 ± 2.7* | 14.8 ± 2.8* |
Leptin (ng/ml) | 8.6 ± 2.4 | 19.6 ± 3.0* | 20.0 ± 3.2* |
IL-6 (pg/ml) | 1.2 ± 0.2 | 1.9 ± 0.5 | 2.4 ± 0.4* |
VO2max (ml · kg−1 · min−1) | 21.1 ± 2.3 | 20.8 ± 2.6 | 16.4 ± 0.4 |
Work | |||
Low intensity (W) | 54 ± 5 | 53 ± 4 | 46 ± 2 |
Moderate intensity (W) | 79 ± 7 | 77 ± 6 | 67 ± 3 |
Data are mean ± SE.
P < 0.05 vs. lean;
P < 0.05 vs. obese.